Skip to main content
Elsevier

Exploring Nanocarriers in Breast Cancer Management

  • 1st Edition - May 21, 2026
  • Latest edition
  • Editors: Amarjitsing Rajput, Satish Mandlik, Praveen Subbappa, Sudarshan Singh
  • Language: English

Exploring Nanocarriers in Breast Cancer Management comprehensively delves into the realm of nanocarrier systems, which have shown immense potential in the management of breast… Read more

Back to School

Start strong. Study with purpose.

Save up to 25% on trusted learning resources

Shop now

Description

Exploring Nanocarriers in Breast Cancer Management comprehensively delves into the realm of nanocarrier systems, which have shown immense potential in the management of breast cancer. The scope of this book encompasses a thorough exploration of various nanocarrier systems, including, amongst others, liposomes, niosomes, and microneedles. It highlights recent advancements in these systems and their promising results in breast cancer treatment. Additionally, the book addresses the crucial aspects of toxicity and regulatory considerations associated with nanocarriers. It aims to provide a foundational understanding of nanocarriers, their unique features, and their significant role in breast cancer management.

As breast cancer remains one of the most prevalent forms of cancer today, with no definitive cure currently available, this book is an essential resource for researchers, healthcare professionals, and anyone interested in cutting-edge developments in breast cancer treatment.

Key features

  • Explores various, promising nanocarriers and their roles in breast cancer management, providing a comprehensive understanding of their applications
  • Examines the regulatory aspects and toxicities associated with different nanocarrier systems, offering valuable insights for researchers and healthcare professionals
  • Highlights recent advancements in nanocarrier technology, showcasing the latest developments and their potential impact on breast cancer treatment

Readership

Researchers working across the biosciences in fields of oncology, and nanotechnology

Table of contents

1. Fundamentals and recent advances in breast cancer treatment
Deepa Mandlik

2. Microneedles: An emerging approach for management of breast cancer
Shounak Kulkarni, Sakshi Wani, Prashant Pingale, Anjali Pingale

3. Niosomes: Nonionic surfactant-based system in breast cancer
Ushasi Das, Adarsha Bachhar, Shila Barman, Arindam Sarkar, Pratik Bhardwaj, Sanchita Mandal

4. Solid lipid nanoparticles in improving the therapeutic effectiveness of anticancer compound
Dhvani Padhiyar, Anam Sami, Aditi Bariya, Harsh Shah, Tejal Mehta, Shital Butani

5. Nanostructured lipid carrier: Second-generation nanoparticles in breast cancer managemen
Dipak S. Thorat, Ushasi Das, Yogesh Ushir, Sudarshan Singh

6. Innovative way of treating breast cancer using carbon nanomaterials
Mudliyar Siddharth, Mathur Ishita, Sandbhor Puja

7. Gold nanoparticles: Promising metallic nanoparticles for effective breast cancer
Pooja Nagime, Sudarshan Singh, Dipak S. Thorat

8. Revolutionizing breast cancer therapy with silver nanoparticles: Mechanisms and applications
Ishrat Nazir, Ashish Garg, Dipak S. Thorat, Sudarshan Singh

9. Exploring the potential of liposomes in breast cancer therapeutics
Gandhali Ghaisas, Amarjitsing Rajput, Vaishali Londhe

10. Exosome-based therapy for breast cancer treatment
Kulkarni Madhur, Aphale Shama, Sharma Nilesh Kumar, Shreya Mohite, Singh Mansaa, Rajput Shweta, Sant Shilpa

11. Enhanced drug delivery in breast cancer: The role of polymeric micelles
Akash Podutwar, Amol Tagalpallewar, Akshay Baheti, Alap Choudhari, Swati Jagdale

12. Dendrimer-based approaches in breast cancer management
Chandrima Kundu, Vijay Singh Parihar, Minna Kellomäki, Sougata Ghosh

13. Cutting-edge approaches in breast cancer treatment: The role of quantum dots/mesoporous silica nanoparticles
Mohit Angolkar, Sharanya Paramshetti, K.M. Asha Spandana, Riyaz Ali M. Osmani, Adel Al Fatease, Ali H. Alamri, Umme Hani, Ekta Singh

14. Recent advancements in breast cancer therapy
Krishna Sanka, Harsha Jain, Satish Rojekar, Ramesh Jadhav, Saurabh Maru, Mahendra Kumar Prajapati

Product details

  • Edition: 1
  • Latest edition
  • Published: May 21, 2026
  • Language: English

About the editors

AR

Amarjitsing Rajput

Dr. Amarjitsing Rajput is currently working as an Assistant Professor in the Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth, Deemed to be University, Pune, Maharashtra, India. He received his Ph. D. from Department of Pharmaceutics Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat in 2021. He completed his M. Pharmacy in Pharmaceutics from North Maharashtra University, Jalgaon, Maharashtra. During his doctoral research, he worked on nanostructured lipid carriers and liposomes to manage Alzheimer’s disease. He continued his Postdoctoral Research at the Department of Biosciences and Bioengineering (BSBE), Indian Institute of Technology Bombay (IITB), Mumbai, India. His area of research includes nanocarriers, microneedle technology, brain targeting, and transdermal drug delivery to manage skin diseases. To his credit, he has more than 35 publications in numerous National and International journals of repute and 15 book chapters. Moreover, he reviews many esteemed international journals,

Affiliations and expertise
University of Pune, India

SM

Satish Mandlik

Dr. Satish K. Mandlik is currently serving as an Associate Professor in the Department of Pharmaceutics at Bharati Vidyapeeth (Deemed to be University)'s Poona College of Pharmacy, Pune, Maharashtra, India. With over 18 years of teaching and research experience, he has made significant contributions to pharmaceutical education, research, and academic development. Dr. Mandlik completed his Bachelor of Pharmacy (B. Pharm.) from the University of Pune, securing Fourth Rank in the university. He obtained his Master of Pharmacy (M. Pharm.) in Quality Assurance from Goa University, where he was awarded First Rank for his outstanding academic performance. An accomplished researcher and academician, Dr. Mandlik has published more than 50 research papers in reputed national and international peer-reviewed journals. His scholarly contributions have earned him an h-index of 17 with more than 1,450 citations, reflecting the quality and impact of his research. He has also authored more than Six Pharmaceutical books and contributed Eight international book chapters published by renowned publishers. Dr. Mandlik is a recognized PG and Ph.D. Guide and his commitment to research has been recognized through research grants exceeding ₹8 lakhs received from various funding agencies. His major research interests include nanotechnology-based drug delivery systems, targeted drug delivery, Quality by Design (QbD), Design of Experiments (DoE), pharmaceutical optimization techniques, formulation development, and pharmaceutical quality assurance. He has actively contributed to research in advanced drug delivery systems and pharmaceutical product development, with a focus on translating scientific innovations into practical healthcare solutions.

Affiliations and expertise
Department of Pharmaceutics, Poona College of Pharmacy Bharti Vidyapeeth Deemed University Pune, Maharashtra, India

PS

Praveen Subbappa

Mr. Praveen Subbappa is a seasoned pharmaceutical executive with over 25 years of experience in the industry. Currently, he serves as the Associate Vice President of Alliance Management at Azurity Pharmaceuticals in the USA. Praveen holds a postgraduate degree in Pharmaceutics from the Government College of Pharmacy, Bengaluru. Throughout his distinguished career, Praveen has held pivotal roles in renowned pharmaceutical companies such as Dr. Reddy’s Laboratories Inc, Slayback Pharma LLC, and Bharat Serums & Vaccines, where he has led critical functions such as Research & Development, Technology Transfer, and Regulatory Affairs
Affiliations and expertise
Azurity Pharmaceuticals, USA

SS

Sudarshan Singh

Dr. Sudarshan Singh is a Frontier Proactive Research scholar at the Faculty of Pharmacy, Chiang Mai University, Thailand. He holds five patents, is approved as a PhD guide by Pacific University, Rajasthan, and is a life member of bodies including the Society of Pharmacovigilance India. He has received research and travel grants from the governments of Gujarat, ICMR, and other institutions.

His current research focuses on 3D-printed implantable green composites with polymeric biomaterials to address dermal inflammation, alongside multifunctional biomaterial development for drug delivery. Previous work involved lipid vesicular curcuminoid analogues as biodegradable scaffolds for intracellular uptake and anti-inflammatory response studies. His postdoctoral work at Prince of Songkhla University centered on biodegradable antibacterial nanoparticle wound dressings tested across multiple cell lines.

Dr. Singh is proficient in a wide range of analytical techniques, including SEM-EDX, NMR, XRD, HPLC, LC-MS, confocal microscopy, and flow cytometry.

Affiliations and expertise
Frontier Proactive Research Scholar, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand

View book on ScienceDirect

Read Exploring Nanocarriers in Breast Cancer Management on ScienceDirect